Year: 2025
Type: article
Abstract: Biologic switching in psoriasis has become increasingly common as therapeutic options continue to expand in real-world practice.Although lack of efficacy remains the main determinant of switching in psoriasis, the roles of safety concerns, economic reasons, and patient preferences are emerging as important considerations of biologic switching.Furthermore, biologic switching is now regarded as an essential and routine aspect of long-term management in moderate-to-severe psoriasis, rather than a one-time therapeutic decision.This review outlines the fundamental concepts and types of biologic switching (interclass, intraclass) in psoriasis and discusses future directions for biologics from the perspective of long-term treatment sequencing.
Source: Daehan geonseon hakoeji (Online)
Authors: Yun Su Eun, Euy Hyun Chung
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W7117124642